CTKB:NASDAQ, Cytek Biosciences, Inc.

CTKB stock overview

Cytek Biosciences, Inc. (CTKB:NASDAQ) closed at $6.12 on November 20, 2026, down 3.16% on the day. The stock trades 4.2% below its 52-week high of $6.39 and 84.9% above its 52-week low of $3.31. Over the past year, it gained 4.8%. Cytek Biosciences, Inc. is part of the Health Care sector.

Key figures

Price
$6.12
Day change
-3.16%
Volume
1,765,925
Average volume
1,297,664
Market cap
800M+
52-week range
$3.31 – $6.39
50-day average
$5.60
200-day average
$4.69

Price action over the past year

In 252 trading sessions since November 20, 2025, CTKB closed higher on 129 days (51%). Its best day was November 21, 2025 (+12.86%) and its worst was October 6, 2026 (-11.66%). The stock moved 10% or more in a single session 4 times.

Recent signals

CTKB news

About Cytek Biosciences, Inc.

Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of cell analysis tools by leveraging novel technical approaches. Its core instruments, the Aurora and Northern Lights systems, are the first full spectrum flow cytometers able to deliver high-resolution, high-content, and high-sensitivity cell analysis by utilizing the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells.

Similar stocks

Find more stocks like CTKB with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.